MILAN, May 12 (Reuters) – Shot of kidneys for the Campari on the stock exchange that, downstream of the first quarter results, updates the minimum seat and then point coming straight upward to gain three percent in a market that moves back by about 1%.
The market digests the quarter, which recorded net sales ahead of expectations of consensus and amounted to 327.4 million, the result of organic growth of 4.2% and an exchange rate effect of 6.6%. But, above all, analysts point out tones more decidedly optimistic statements of the CEO Bob Kunze-Concewitz that, in a statement, confirmed it expects an improvement in operating margins during 2015.
“The results are slightly higher than my estimates, the CEO in the press seemed more optimistic than the cautious tone of the ‘full year’ and confirmed the forecast expansion in operating margins,” said an analyst.
EBIT before non-recurring income and expenses amounted to 44.5 million, in line with consensus of 44 million.
“The numbers are in line, what impresses is the outlook,” says another analyst.
Waiting for the 13 conference call with analysts.
www.reuters.it On other news Reuters in Italian. The top news also on www.twitter.com/reuters_italia
© Thomson Reuters 2015 All rights assigns Reuters.
No comments:
Post a Comment